SM

Sivagnanam Madesh Kumar

Active Director Director DIN 10065603
DIN 10065603 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Sivagnanam Madesh Kumar

Data last updated:

Sivagnanam Madesh Kumar is a Director at Amerlim Biotech Private Limited (since 2023). Amerlim Biotech Private Limited reported revenue of ₹4.4 Lakh (FY 2024).

DIN 10065603
Primary Designation Director
First Appointment 10 Mar 2023
Oldest Company Age 3 yrs
Largest company Amerlim Biotech Private Limited · ₹4.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amerlim Biotech Private Limited U46901TN2023PTC158714
Director10 Mar 20232023₹4.4 Lakh (FY 2024)Active

Board colleagues of Sivagnanam Madesh Kumar

NameDINCompanyDesignation
Venkatesan Prema10900786Amerlim Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amerlim Biotech Private Limited
Premium access

Shareholding and investment profile for Sivagnanam Madesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivagnanam Madesh Kumar

Sivagnanam Madesh Kumar currently holds 1 directorship: Amerlim Biotech Private Limited (Director, since 10 Mar 2023, revenue ₹4.4 Lakh (FY 2024)).

Sivagnanam Madesh Kumar was first appointed on 10 Mar 2023 as Director at Amerlim Biotech Private Limited.

The current boards of Sivagnanam Madesh Kumar's companies include Venkatesan Prema (Amerlim Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available